General characteristics | n(%) |
---|---|
Male/female | 19 (42.2 )/26 (57.8) |
Mean age | 45.7 years (95% CI 42.4–49.0 years) |
Risk | |
Blood transfusion | 25 (55.5) |
Multiple sex partners | 6 (13.3) |
History of surgery | 2 (4.4) |
Dental care | 1 (2.2) |
Intravenous drug user | 2 (4.4) |
Unidentified source of infection | 9 (20) |
Liver disease status | |
Active hepatitis | 21 (46.6) |
Cirrhosis | 23 (51.1) |
Hepatocellular carcinoma | 1 (2.3) |
Laboratory data | |
Range serum viral load (log IU/ml) | 2.31–6.68 |
Mean serum viral load (log IU/ml) | 5.46 (95% CI 5.23–5.70) |
Range prothrombin time (%) | 45–104 |
Mean prothrombin time (%) | 79 (95% CI 73–84) |
Range platelet count (μl) | 5.3 × 104–3.0 × 105 |
Mean platelet count (μl) | 1.55 × 105 (1.30 × 105–1.80 × 105) |
HCV genotype and subtype | |
1a | 17 (37.8) |
1b | 20 (44.4) |
2a | 1 (2.2) |
2b | 3 (6.7) |
3a | 4 (8.9) |